WEBINAR FIVE Testing for COVID-19 and Effectiveness of Vaccinations

Dean Whiting, CEO Pathology Technology Australia

Dean graduated from UWA with a Master of Science in Clinical Biochemistry and worked in pathology labs for 15 years. Moved to sales, marketing and executive management roles, mostly in large IVD technology companies. Has lived and worked in the USA, China and almost all Asian and sub-continental countries. Dean has an extensive knowledge of the pathology testing and technology sector. He supported the early days of Australia’s Bowel Cancer Screening program roll out. Currently heading up Pathology Technology Australia - the peak body representing companies that develop, manufacture and supply the technology and consumables so vital to testing in human health. This includes the technology used to detect and sequence the COVID-19 virus and its RNA. This has also been vital in creating some of the vaccines available today.

Dean's presentation will cover:

General overview of COVID-19 vaccines and immunity
Key technologies and terminologies around detection and sequencing of the COVID-19 virus and why it's important
Vaccine validation, monitoring acceptance and challenges in their roll out

When: Thursday, April 8 at 7pm (AEST)

Cost: FREE for AMWA members; $20 for non-members

AMWA WEBINAR SERIES

Starting in March we are delighted to deliver a series of AMWA webinars: ‘The COVID-19 vaccine – your questions answered’. Presented by an impressive expert line-up we’ll be covering vaccine development, approval and safety processes, vaccine implementation, strategies to address vaccine hesitancy, diagnostic testing post-vaccine as well as vaccine access.